These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37186942)

  • 1. The Dawn of a New Era: Targeting the "Undruggables" with Antibody-Based Therapeutics.
    Qian L; Lin X; Gao X; Khan RU; Liao JY; Du S; Ge J; Zeng S; Yao SQ
    Chem Rev; 2023 Jun; 123(12):7782-7853. PubMed ID: 37186942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging new therapeutic antibody derivatives for cancer treatment.
    Jin S; Sun Y; Liang X; Gu X; Ning J; Xu Y; Chen S; Pan L
    Signal Transduct Target Ther; 2022 Feb; 7(1):39. PubMed ID: 35132063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies and associates: Partners in targeted drug delivery.
    Kennedy PJ; Oliveira C; Granja PL; Sarmento B
    Pharmacol Ther; 2017 Sep; 177():129-145. PubMed ID: 28315359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-Oligonucleotide Conjugates as Therapeutic, Imaging, and Detection Agents.
    Dovgan I; Koniev O; Kolodych S; Wagner A
    Bioconjug Chem; 2019 Oct; 30(10):2483-2501. PubMed ID: 31339691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Mediated Enzyme Therapeutics and Applications in Glycogen Storage Diseases.
    Zhou Z; Austin GL; Shaffer R; Armstrong DD; Gentry MS
    Trends Mol Med; 2019 Dec; 25(12):1094-1109. PubMed ID: 31522955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.
    Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S
    PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy.
    Tushir-Singh J
    Expert Opin Biol Ther; 2017 Mar; 17(3):325-338. PubMed ID: 27977315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antibodies to target cancer therapeutics.
    Goldenberg DM; Sharkey RM
    Expert Opin Biol Ther; 2012 Sep; 12(9):1173-90. PubMed ID: 22650606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site Selective Antibody-Oligonucleotide Conjugation via Microbial Transglutaminase.
    Huggins IJ; Medina CA; Springer AD; van den Berg A; Jadhav S; Cui X; Dowdy SF
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31509944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-Biopolymer Conjugates in Oncology: A Review.
    Chavda VP; Balar PC; Teli D; Davidson M; Bojarska J; Apostolopoulos V
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation antibody drugs: pursuit of the 'high-hanging fruit'.
    Carter PJ; Lazar GA
    Nat Rev Drug Discov; 2018 Mar; 17(3):197-223. PubMed ID: 29192287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of precision antibody conjugates using proximity-induced chemistry.
    Cao YJ; Yu C; Wu KL; Wang X; Liu D; Tian Z; Zhao L; Qi X; Loredo A; Chung A; Xiao H
    Theranostics; 2021; 11(18):9107-9117. PubMed ID: 34522229
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody-oligonucleotide conjugates enter the clinic.
    Mullard A
    Nat Rev Drug Discov; 2022 Jan; 21(1):6-8. PubMed ID: 34903879
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody conjugate therapeutics: challenges and potential.
    Teicher BA; Chari RV
    Clin Cancer Res; 2011 Oct; 17(20):6389-97. PubMed ID: 22003066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-DM1 conjugates as cancer therapeutics.
    Lopus M
    Cancer Lett; 2011 Aug; 307(2):113-8. PubMed ID: 21481526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.
    Hong Y; Nam SM; Moon A
    Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control.
    Lucchi R; Bentanachs J; Oller-Salvia B
    ACS Cent Sci; 2021 May; 7(5):724-738. PubMed ID: 34079893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted drug delivery using immunoconjugates: principles and applications.
    Pasquetto MV; Vecchia L; Covini D; Digilio R; Scotti C
    J Immunother; 2011; 34(9):611-28. PubMed ID: 21989410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Design of next generation antibody drug conjugates].
    Zhu GD; Fu YX
    Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.